[1] |
FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong.
Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184.
|
[2] |
LIU Min, CHEN Yan, LIU Wendong, WANG Haixue.
Updates and reflections on expedited reporting of safety information during drug clinical trials
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 98-101.
|
[3] |
JIANG Wenshuo, YANG Li.
Adverse drug reaction among 694 patients in an epilepsy physician-pharmacist joint clinic
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 102-106.
|
[4] |
MA Ruize, CHEN Zhihai.
The latest progress of small molecule anti-SARS-CoV-2 drugs
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 961-966.
|
[5] |
SHEN Yanjie, WU Yiqing.
Management of adverse events during clinical trials
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 982-986.
|
[6] |
LIU Wendong, CUI Huanhuan, WANG Xiaohan, SU Xian, WANG Haixue.
Status and thinking of Parmacovigilance regulatory system during clinical trials of the pediatric drug in China
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1002-1006.
|
[7] |
ZHANG Bing, SA Rina, ZHANG Xiaomeng, ZHANG Dan, LIN Zhijian, WANG Yu.
Research progress in pharmacogenic cardiotoxicity
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 841-847.
|
[8] |
SHI Xiangfen, SUN Zhiyong, ZHANG Xufeng, LU Xiaojing, DU Shuzhang, ZHANG Xiaojian.
Whole process management of narcotic drugs and psychotropic drugs based on intelligent information management system
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 899-903.
|
[9] |
DILHUMAR Dilmurat, SHI Wei, WANG Jiabo, GAO Yuan.
Research progress in safe use of Psoralea corylifolia based on evolution of toxicity/efficacy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 939-945.
|
[10] |
YANG Liang, TAO Rui, HU Huizi, WANG Zihan, ZHANG Yan, DONG Yan, CHU Zhaoyi, ZHANG Zizhen, GENG Jiahao, LI Shuai, XU Nuo, MA Zengchun, GAO Yue.
Research progress in clinical use of large-dose Radix Aconiti Lateralis Preparata
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 946-949.
|
[11] |
LI Yamei, SHUI Rong.
Research progress in tofacitinib for juvenile idiopathic arthritis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 956-960.
|
[12] |
HUANG Cuili, GAO Ao, WANG Jiaxi, GUO Haili, XU Xiaohan, CHENG Yinchu, GUO Daihong.
Automatic monitoring and assessment of antibiotics-related thrombocytopenia
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 807-811.
|
[13] |
CHEN Jie, QIN Kan.
Evaluation of individualized parenteral nutrition delivery
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 812-816.
|
[14] |
LIU Jing, XIA Liang, ZHANG Shijie.
Pharmaceutical care of a patient with acute pancreatitis complicated with multiple drug allergy undergoing drug stimulation test
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 822-824.
|
[15] |
YU Lecheng, HAO Kunyan, FAN Ye.
Clinical diagnosis of Chinese-herbal-induced liver injury
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 481-488.
|